Plasma cystine/methionine ratio is associated with left ventricular diastolic function in patients with heart disease

Elevated circulating homocysteine (Hcy) is a well-known risk factor for cardiovascular diseases (CVDs), including coronary artery disease (CAD) and heart failure (HF). It remains unclear how Hcy and its derivatives relate to left ventricular (LV) diastolic function. The aim of the present study was to investigate the relationship between plasma Hcy-related metabolites and diastolic dysfunction (DD) in patients with heart disease (HD). A total of 62 HD patients with preserved LV ejection fraction (LVEF ≥ 50%) were enrolled. Plasma Hcy and its derivatives were measured by liquid chromatography‒mass spectrometry (LC–MS/MS). Spearman’s correlation test and multiple linear regression models were used to analyze the associations between metabolite levels and LV diastolic function. The cystine/methionine (CySS/Met) ratio was positively correlated with LV diastolic function, which was defined from the ratio of mitral inflow E and mitral e ′ annular velocities ( E / e ′) (Spearman’s r = 0.43, p < 0.001). When the subjects were categorized into two groups by E / e ′, the high- E / e ′ group had a significantly higher CySS/Met ratio than the low- E / e ′ group ( p = 0.002). Multiple linear regression models revealed that the CySS/Met ratio was independently associated with E / e ′ after adjustment for age, sex, body mass index (BMI), diabetes mellitus, hypertension, chronic kidney disease (CKD), hemoglobin, and lipid peroxide (LPO) {standardized β (95% CI); 0.14 (0.04–0.23); p = 0.005}. Hcy, CySS, and Met did not show a significant association with E / e ′ in the same models. A high plasma CySS/Met ratio reflected DD in patients with HD.